Posts Tagged ‘Versican’
Highlights of recent US patent applications on protein biomarkers and molecular diagnostics.
1. Biomarker for monitoring the efficacy of aspirin treatment
2. Biomarker for predicting the efficacy of trental (pentoxifylline) therapy in transitory ischemic attacks (TIA)/stroke patients
3. Biomarker for identifying infants with congenial heart diseases requiring cardiac surgery
4. Versican as a biomarker of renal injury
5. Fecal microRNA (miRNA) biomarkers for the detection of hereditary colorectal cancers
6. Real-time PCR method for the detection of Clostridium botulinum
7. Biomarkers for diagnosing susceptibility to insulin resistance in Hispanic Americans
8. Biomarkers for predicting response to antibody therapy in rheumatoid arthritis patients
9. Biomarkers for the detection of vasculitis in Wegener’s granulomatosis, microscopic polyangiitis and Horton’s disease
10. Immunodiagnostic biomarker for the sero-detection of Anaplasma phagocytophilum
11. Peptide biomarkers for the diagnosis of rheumatoid arthritis
12. Urinary biomarker for diagnosing HIV associated nephropathy (HIVAN)
Details: http://www.sciclips.com/sciclips/biomarker-news.do
Related tools:
1. Comprehensive cancer biomarker database with companion diagnostics pathway
2. Bioprotocols
3. Drug discovery news
4. Biomarker news
Related blogs:
Strategies for Rational and Personalized Cancer Biomarker Discovery
1. Cancer Theranostics – Potential Applications of Cancer Biomarker Database
Recent Comments